Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial
GST-HG171治疗轻度至中度COVID-19成人患者的疗效和安全性：一项随机、双盲、安慰剂对照的2/3期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102582
Lu, Hongzhou; Zhang, George; Mao, John; Chen, Xiaochun; Zhan, Yangqing; Lin, Ling; Zhang, Tianxiang; Tang, Yanan; Lin, Feng; Zhu, Feiyue; Lin, Yuanlong; Zeng, Yiming; Zhang, Kaiyu; Yuan, Wenfang; Liang, Zhenyu; Sun, Ruilin; Huo, Liya; Hu, Peng; Lin, Yihua; Zhuang, Xibin; Wei, Zhaohui; Chen, Xia; Yan, Wenhao; Yan, Xiuping; Mu, Lisa; Lin, Zhuhua; Tu, Xinyu; Tan, Hongshan; Huang, Fuhu; Hu, Zhiqiang; Li, Hongming; Li, Guoping; Fu, Haijun; Yang, Zifeng; Chen, Xinwen; Wang, Fu-Sheng; Zhong, Nanshan
